Charles River Laboratories International Inc
NYSE:CRL
Relative Value
The Relative Value of one
CRL
stock under the Base Case scenario is
262.1
USD.
Compared to the current market price of 182.37 USD,
Charles River Laboratories International Inc
is
Undervalued by 30%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
CRL Competitors Multiples
Charles River Laboratories International Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Charles River Laboratories International Inc
NYSE:CRL
|
9B USD | 2.2 | -107.3 | 12.2 | 23.2 | |
| US |
P
|
PerkinElmer Inc
LSE:0KHE
|
1.1T USD | 384.4 | 4 552.1 | 1 443.2 | 3 083.5 | |
| US |
|
Thermo Fisher Scientific Inc
NYSE:TMO
|
204.8B USD | 4.6 | 30.5 | 21.2 | 28.4 | |
| US |
|
Danaher Corp
NYSE:DHR
|
152.3B USD | 6.2 | 42.2 | 23.3 | 35.5 | |
| KR |
|
Samsung Biologics Co Ltd
KRX:207940
|
75.9T KRW | 13.8 | 47.5 | 27.9 | 37.2 | |
| CH |
|
Lonza Group AG
SIX:LONN
|
35.6B CHF | 5.5 | 37.9 | 27.9 | 27.9 | |
| CN |
|
WuXi AppTec Co Ltd
SSE:603259
|
280B CNY | 6.3 | 18.7 | 18.8 | 18.8 | |
| US |
|
Agilent Technologies Inc
NYSE:A
|
37B USD | 5.3 | 28.3 | 20.6 | 24.4 | |
| US |
|
IQVIA Holdings Inc
NYSE:IQV
|
30.6B USD | 1.9 | 23.8 | 12.2 | 18.3 | |
| US |
|
Mettler-Toledo International Inc
NYSE:MTD
|
28.3B USD | 7.2 | 33.8 | 24.4 | 27.1 | |
| US |
|
Waters Corp
NYSE:WAT
|
22.6B USD | 7.2 | 34.3 | 22.2 | 27.6 |